Cell cycle regulatory proteins in podocyte health and disease

被引:56
作者
Marshall, Caroline B. [1 ]
Shankland, Stuart J. [1 ]
机构
[1] Univ Washington, Div Nephrol, Seattle, WA 98195 USA
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2007年 / 106卷 / 02期
关键词
cell cycle; cyclins; CDK inhibitors; glomerulus; podocyte; hypertrophy; apoptosis; proliferation; DNA damage;
D O I
10.1159/000101793
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The glomerular visceral epithelial cell, or podocyte, is a highly specialized and terminally differentiated cell that is fundamental to the integrity of the glomerular filtration barrier and functions to prevent urinary protein leakage and to oppose intracapillary hydrostatic pressure. Common to many human kidney diseases and experimental animal models is a strong association between podocyte injury and the development of progressive kidney disease. Studies have shown that a decline in podocyte number strongly correlates with, and likely underlies, proteinuria and the progression to glomerulosclerosis. Maintenance of podocyte differentiation, essential to its normal structure and function, is challenged in the setting of glomerular injury, with very divergent outcomes dependent upon the inciting injury. In response to injury, podocytes may undergo several cell fates, including proliferation, de-differentiation, hypertrophy, apoptosis, or necrosis. Common to these potential outcomes of renal injury is their ultimate regulation at the level of the cell cycle. Positive regulators (cyclins and cyclin-dependent kinases) and negative regulators (cyclin-dependent kinase inhibitors) coordinate the cell cycle. There is now a large body of literature confirming the importance of cell cycle regulatory proteins in the cellular response to injury. Emerging lessons from mouse knockout experiments highlight that the cell cycle machinery operates differently in distinct cell types. Recent studies focusing on the roles of cell cycle regulatory proteins specifically in podocytes have provided important clues on how these proteins operate to constrain cell proliferation and preserve differentiation in health, and how they modulate the dysregulated phenotype in diseased states. In disease, both a failure to regenerate lost podocytes and an inappropriate proliferative response can have profound consequences for glomerular structure and function. Here, we will review the latest advances in understanding the roles of cell cycle regulatory proteins in diseases of the podocyte. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:E51 / E59
页数:9
相关论文
共 20 条
  • [1] The lack of cyclin kinase inhibitor p27Kip1 ameliorates progression of diabetic nephropathy
    Awazu, M
    Omori, S
    Ishikura, K
    Hida, M
    Fujita, H
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03): : 699 - 708
  • [2] Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms
    Baba, M
    Wada, J
    Eguchi, J
    Hashimoto, I
    Okada, T
    Yasuhara, A
    Shikata, K
    Kanwar, YS
    Makino, H
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3222 - 3234
  • [3] Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies
    Barisoni, L
    Mokrzycki, M
    Sablay, L
    Nagata, M
    Yamase, H
    Mundel, P
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 137 - 143
  • [4] Cyclin I protects podocytes from apoptosis
    Griffin, Sian V.
    Olivier, J. Paul
    Pippin, Jeffrey W.
    Roberts, James M.
    Shankland, Stuart J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (38) : 28048 - 28057
  • [5] Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology
    Griffin, SV
    Hiromura, K
    Pippin, J
    Petermann, AT
    Blonski, MJ
    Krofft, R
    Takahashi, S
    Kulkarni, AB
    Shankland, SJ
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) : 1175 - 1185
  • [6] Cell cycle control in glomerular disease
    Griffin, SV
    Pichler, R
    Dittrich, M
    Durvasula, R
    Shankland, SJ
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 24 (04): : 441 - 457
  • [7] Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats
    Hoshi, S
    Shu, YJ
    Yoshida, F
    Inagaki, T
    Sonoda, J
    Watanabe, T
    Nomoto, K
    Nagata, M
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 25 - 35
  • [8] The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis
    Kim, YG
    Alpers, CE
    Brugarolas, J
    Johnson, RJ
    Couser, WG
    Shankland, SJ
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2349 - 2361
  • [9] Kuan CJ, 1998, J AM SOC NEPHROL, V9, P986
  • [10] Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo
    Marshall, C. B.
    Pippin, J. W.
    Krofft, R. D.
    Shankland, S. J.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (11) : 1962 - 1973